Teaching Health Resilience in a Hospital Setting: A Peer-led Intervention
Key facts
- Who runs it
- University of Pennsylvania
- Where
- Pittsburgh, United StatesSee the 3 sites
- Trial code
- Status
- Recruiting
- People taking part
- 300 people, planned
- Started
- 18 Feb 2025
- Expected to end
- 31 Aug 2027
- Type of study
- Interventional, 2 groups
- Treatments tested
- Peer Intervention
- Enhanced Usual Care
- Record updated
- 13 November 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Participants who are: a) admitted to University of Pittsburgh Medical Center (UPMC) Shadyside Hospital, UPMC Presbyterian-Montefiore Hospital, UPMC Mercy Hospital for inpatient or observation status, or b) seen in the Emergency Department setting at UPMC Presbyterian-Montefiore Hospital and UPMC Mercy Hospital
- Participants must have a current diagnosis of Opioid Use Disorder based on the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) diagnostic criteria
- Participants must be at least 18 years of age on day of admission
- Participants must be able to speak and read English
Who cannot take part
- Participants diagnosed with dementia and/or cognitive impairments
- Participants with acute psychiatric complications, such as schizophrenia with acute psychosis, acute mania, or suicidal ideation (which may impact the ability of a participant to consent and actively participate in treatment)
- Participants who are pregnant or lactating at onset of study
- Participants who cannot read or speak English
This trial is currently available in United States.
- Upmc Presbyterian Montefiore HospitalPittsburgh, United StatesContact: Research Program CoordinatorTaking people
- UPMC-Mercy HospitalPittsburgh, United StatesContact: Research Program CoordinatorNot yet recruiting
- UPMC-Shadyside HospitalPittsburgh, United StatesContact: Research Program CoordinatorNot yet recruiting
About the trial
What the trial wants to find out
The purpose of the study is to develop an acceptable, feasible, and effective peer-led bundle of health resilience and promotion services to be delivered in the hospital setting, called the THRIVE intervention.
Read full original descriptionShow less
The main question it aims to answer is: Will participants receiving the THRIVE intervention have a reduced risk of self-reported non-fatal overdoses OR skin/soft tissue infections compared to participants receiving enhanced usual care?
Researchers will compare the THRIVE model to enhanced usual care to see if the THRIVE model helps participants reduce their number of self-reported non-fatal overdoses OR skin/soft tissue infections.
Intervention participants will:
* Receive one in-person session from a peer support specialist while in the hospital * Receive weekly text messages from the peer support specialist for a 12-week period * Receive monthly, multiple-choice assessments via text message at Month 1, 2, 3, 4, 5, and 6 * Complete a baseline, 3-month, and 6-month assessment with Research Assistants
Enhanced usual care participants will:
* Receive a handout with health resilience education and resources in their local area * Receive monthly, multiple-choice assessments via text message at Month 1, 2, 3, 4, 5, and 6 * Complete a baseline, 3-month, and 6-month assessment with Research Assistants
The 2 groups in the trial
- Peer InterventionTreatment being tested
- Enhanced Usual CareOther group
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Teaching Health Promotion and Resilience in Varied Environments: a Peer-led Intervention Following Hospital Discharge
- Record updated
- 13 November 2026